Clinical Trial Update: Temsirolimus in Myelodysplastic Syndrome (MDS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating temsirolimus for myelodysplastic syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Temsirolimus (temsirolimus)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Myelodysplastic Syndrome | Phase 2 | Status: TERMINATED